The concept sounds like the stuff of science fiction: take a pill, and suddenly new tissues grow to replace damaged ones
Researchers at Case Western Reserve and UT Southwestern Medical Center this week announced that they have taken significant steps toward turning this once-improbable idea into a vivid reality. In a study published in the June 12 edition of Science, they detail how a new drug repaired damage to the colon, liver and bone marrow in animal models — even going so far as to save the lives of mice who otherwise would have died in a bone marrow transplantation model.
“We are very excited,” said Sanford Markowitz, MD, PhD, the Ingalls Professor of Cancer Genetics at the university’s School of Medicine and a medical oncologist at University Hospitals Case Medical Center’s Seidman Cancer Center. “We have developed a drug that acts like a vitamin for tissue stem cells, stimulating their ability to repair tissues more quickly. The drug heals damage in multiple tissues, which suggests to us that it may have applications in treating many diseases.”
The institutions collaborating on this work next hope to develop the drug — now known as “SW033291” — for use in human patients. Because of the areas of initial success, they first would focus on individuals who are receiving bone marrow transplants, individuals with ulcerative colitis, and individuals having liver surgery. The goal for each is the same: to increase dramatically the chances of a more rapid and successful recovery.
The key to the drug’s potential involves a molecule the body produces that is known as prostaglandin E2, or PGE2. It is well established that PGE2 supports proliferation of many types of tissue stem cells. Markowitz and University of Kentucky Professor Hsin-Hsiung Tai earlier had demonstrated that a gene product found in all humans, 15-hydroxyprostaglandin dehydrogenase (15-PGDH), degrades and reduces the amount of PGE2 in the body.
Markowitz, also a Harrington Discovery Institute Scholar-Innovator, and James K.V. Willson, MD, a former Case Western Reserve colleague now at UT-Southwestern, hypothesized that inhibiting 15-PGDH would increase PGE2 in tissues. In so doing, it would promote and speed tissue healing. When experiments on mice genetically engineered to lack 15-PGDH proved them correct, the pair began searching for a way to inactivate 15-PGDH on a short-term basis.
The preliminary work began in test tubes. Yongyou Zhang, PhD, a Case Western Reserve research associate in Markowitz’s lab and a lead author on the study, developed a test where cells glowed when 15-PGDH levels changed. Zhang then traveled to UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center, where Willson serves as director. Zhang and UT Southwestern researchers Bruce Posner, PhD, and Joseph Ready, PhD, collaborated to comb through the center’s library of 230,000 different chemicals. Ultimately they identified one chemical that they found inactivated 15-PGDH.
“The chemical, SW033291, acts in an incredibly potent way,” Markowitz said. “It can inactivate 15-PGDH when added at one part in 10 billion into a reaction mixture, which means it has promise to work as a drug.”
A series of experiments showed that SW033291 could inactivate 15-PGDH in a test tube and inside a cell, and, most importantly, when injected into animal models. The third finding came through collaboration between Markowitz and Stanton L. Gerson, MD, director of the Case Comprehensive Cancer Center, UH Seidman Cancer Center, and the National Center for Regenerative Medicine, as well as the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology.
Case Western Reserve research associate Amar Desai, PhD, worked between the Markowitz and Gerson laboratories to determine the effect of SW033291 on mice that had received lethal doses of radiation and then received a partial bone marrow transplant. Without SW033291, the animals died. With it, they recovered.
From there, more detailed studies showed that mice given SW033291 recovered normal blood counts six days faster than mice that were transplanted without receiving SW033291. In addition, SW033291-treated mice showed faster recovery of neutrophils, platelets and red blood cells. Neutrophils battle infection, platelets prevent bleeding, and red blood cells deliver oxygen throughout the body.
In addition, Desai’s work showed that when SW033291 increases PGE2 in bone marrow, the body also begins to produce other materials that bone marrow stem cells need to survive. Finally, these benefits emerged without any adverse side effects, even at SW033291 doses much higher than would be required for 15-PGDH inhibition.
When investigators treated mice with other diseases, the SW033291 drug again accelerated tissue recovery. For example, the investigators teamed with Fabio Cominelli, MD, PhD, a Case Western Reserve Professor and Chief of the Division of Gastroenterology and Liver Disease, to study a mouse model of ulcerative colitis. SW033291 healed virtually all the ulcers in the animals’ colons and prevented colitis symptoms. In mice where two-thirds of their livers had been removed surgically, SW033291 accelerated regrowth of new liver nearly twice as fast as normally happens without medication.
The Latest on: Tissue regeneration
via Google News
The Latest on: Tissue regeneration
- How do scars form? Fascia function as a repository of mobile scar tissueon December 1, 2019 at 1:58 pm
Researchers found that scars are made from a tissue beneath the skin: fascia. This new knowledge led to further discoveries about scarring mechanisms and the fascia matrix which are crucial for the ...
- Nerve Regeneration Market Size to Reach USD 12695.25 million by 2024 with Accelerated CAGR 11.34%on November 29, 2019 at 6:15 am
Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings. The Global Nerve Regeneration Market is expected to enroll a CAGR of 11.34% to ...
- From Planarians to Parasites: Stem Cells and Regeneration in Flatwormson November 29, 2019 at 4:00 am
press release: Join a discussion about planarians to discover how they use stem cells as a source of new tissue during regeneration and tissue maintenance. You’ll also learn how the UW’s work with ...
- Stem cells do help restore heart function – but in a different wayon November 28, 2019 at 4:22 pm
These cells are characterized by their property of self-renewal and ability to differentiate into many different types of cells. They have long been thought to stimulate tissue repair and regeneration ...
- Graft immaturity and safety concerns in transplanted human kidney organoidson November 27, 2019 at 7:32 pm
For chronic kidney disease, regeneration of lost nephrons with human kidney organoids derived from induced ... but remained immature compared with the neighboring mouse kidney tissue. Ultrastructural ...
- Graphene activates immune cells helping bone regeneration in miceon November 27, 2019 at 1:27 am
These nanosystems can improve bone regeneration, a process that requires interaction between immune and skeletal cells. Delogu and her team have worked to take advantage of the material in the field ...
- Two Duke biomedical engineers are transforming human tissue growth researchon November 26, 2019 at 11:41 pm
Treating humans, she noted, is an entirely different story when it comes to the injection of gels for brain tissue regeneration. “I think about transport and mechanics as just being a huge problem,” ...
- Segra Awarded Nursery License from Health Canada for its Flagship Cannabis Tissue Culture Nurseryon November 26, 2019 at 4:30 pm
Segra’s high tech plant propagation system utilizes a proprietary plant tissue culture process to produce DNA-fingerprinted and verified disease-free plants for shipment to producers. In addition to ...
- Australian researchers create kidney tissue from iPS cellson November 25, 2019 at 3:33 pm
MELBOURNE, Australia – Researchers at the Murdoch Children’s Research Institute in Melbourne are pushing the boundaries on creating kidney tissue from stem cells. For more than two decades, Melissa ...
- Nerve Regeneration and Repair Market 2019: Global Industry Trends, Sales Revenue, Industry Growth by 2024 – MRE Analysison November 24, 2019 at 7:44 pm
Nov 24, 2019 (Heraldkeepers) -- New York, November 25, 2019: Frequency of neurological injury is high, nerve regeneration and repair, a sub field of neural tissue building, is turning into a quickly ...
via Bing News